Posts Tagged ‘drug

September 14, 2020
Our Take: Drug execs, public health officials try to shore up confidence in safety of future COVID-19 vaccine
Read More
September 11, 2020
Podcast 115: Dissecting the PBM Model with Karthik Ganesh
Read More
August 31, 2020
Our Take: CDC changes COVID-19 testing guidance, FDA issues EUA for convalescent plasma; both agencies face backlash
Read More
August 24, 2020
Our Take: Big-name drugmakers make billion-dollar deals; digital ‘unicorn’ once worth $1.5 billion goes for $15 million
Read More
August 17, 2020
Our Take: As federal funding shores up for-profit health systems’ finances, lower utilization increases profits for Kaiser Permanente and top insurers
Read More
August 10, 2020
Our Take: Trump’s executive order, CMS’ proposed payment rules offer hope to rural areas
Read More
August 03, 2020
Our Take: Late-stage trials of COVID-19 vaccine candidates get underway as BARDA agrees to additional funding for vaccine development, production
Read More
July 27, 2020
Our Take: Trump renews efforts to lower drug prices ahead of election
Read More
January 20, 2020
Our Take: New developments ahead for drug development, from genomics to generics
Read More
December 09, 2019
Our Take: Partners rebrands; announces five-year strategic priorities
Read More
November 25, 2019
Our Take: Alternative payment models continue to gain traction, new survey shows
Read More
November 18, 2019
Our Take: U.S. government sues Gilead Sciences in dispute over PrEP patents
Read More
November 11, 2019
Our Take: Haven pilots insurance plans for employees in six states
Read More
November 04, 2019
Our Take: Walgreens ratchets up efforts to boost profitability, will close company-owned in-store clinics
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Reach out to us

Gainey Corporate Center
8777 N Gainey Center Dr, Ste 205
Scottsdale, AZ 85258
(480) 923-0802

Sign up for Our Take
the weekly strategic brief for Health Care Executives

[contact-form-7 id="321" title="Footer Newsletter"]

Posts Tagged ‘drug

Our Take: Drug execs, public health officials try to shore up confidence in safety of future COVID-19 vaccine

Podcast 115: Dissecting the PBM Model with Karthik Ganesh

Our Take: CDC changes COVID-19 testing guidance, FDA issues EUA for convalescent plasma; both agencies face backlash

Our Take: Big-name drugmakers make billion-dollar deals; digital ‘unicorn’ once worth $1.5 billion goes for $15 million

Our Take: As federal funding shores up for-profit health systems’ finances, lower utilization increases profits for Kaiser Permanente and top insurers

Our Take: Trump’s executive order, CMS’ proposed payment rules offer hope to rural areas

Our Take: Late-stage trials of COVID-19 vaccine candidates get underway as BARDA agrees to additional funding for vaccine development, production

Our Take: Trump renews efforts to lower drug prices ahead of election

Our Take: New developments ahead for drug development, from genomics to generics

Our Take: Partners rebrands; announces five-year strategic priorities

Our Take: Alternative payment models continue to gain traction, new survey shows

Our Take: U.S. government sues Gilead Sciences in dispute over PrEP patents

Our Take: Haven pilots insurance plans for employees in six states

Our Take: Walgreens ratchets up efforts to boost profitability, will close company-owned in-store clinics

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Stay Connected

Posts Tagged ‘drug

Sign up for Our Takethe weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Takethe weekly strategic brief for Health Care Executives

Stay Connected

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Sign up for Our Take
the weekly strategic brief for Health Care Executives